There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
Jose Mourinho is struggling to adapt to life in Manchester after taking the manager's job at Old Trafford this summer.
'Flushable' wet wipes are blighting beaches and blocking sewers, costing water companies and tax payers more than £80 million a year.
Two young children who survived the theme park ride crash in Australia reportedly watched helplessly as their mothers were killed.